For too long, women navigating menopause without the option of hormone replacement therapy (HRT) have been left with limited and often ineffective choices. Hot flushes, night sweats, insomnia, brain fog, and the cascading impact on mood and concentration have been dismissed as “part of the journey”—when in truth, they have been one of the leading drivers of absenteeism, burnout, and declining workplace wellbeing.
But that gap in care is finally closing.
NICE has now approved fezolinetant, the first targeted non‑hormonal medication specifically designed to treat moderate to severe vasomotor symptoms such as hot flushes and night sweats. Approximately 500,000 women in England and Wales are expected to benefit from this breakthrough treatment, particularly those who cannot or should not take HRT. [nice.org.uk]
And for employers, the impact could be game‑changing.
Read more: Fezolinetant: Transforming Menopause Care for WomenWhy This Matters for Employers
Menopause symptoms aren’t merely “personal problems”—they are proven workplace issues.
Hot flushes and night sweats can significantly disrupt sleep, energy levels, focus, and daily functioning, leading to higher rates of absenteeism and presenteeism. NICE explicitly acknowledges that these symptoms interfere with concentration, relationships, and the ability to work effectively.
For the first time, women who have historically fallen through the cracks—those with contraindications such as previous deep vein thrombosis, pulmonary embolism, or certain cardiovascular conditions—now have a clinically effective option. I can feel so many women breathing a huge sigh of relief right now (maybe even shedding a tear of joy)! Fezolinetant works by blocking neurokinin‑3 receptors in the brain, which regulate the pathways that trigger vasomotor symptoms. [msn.com]
This is not an antidepressant.
Not a repurposed medication.
Not a “best‑we-can-do” workaround.
Purpose-built, effectively tested, and proven to significantly reduce both the frequency and severity of hot flushes.
For employers, this means:
- Fewer lost workdays due to severe symptoms and broken sleep.
- Improved cognitive performance, focus, and emotional stability.
- Higher retention of experienced women at pivotal career stages.
- A more inclusive culture where women feel supported rather than sidelined.
This is wellbeing strategy in action—not theory.
Why Many Women Still Can’t Access Adequate Care
Even with this medical advancement, the reality remains: menopausal women are one of the most underserved groups in healthcare. Although HRT remains the first-line treatment, large numbers of women simply cannot take it. For them, options have been historically “limited” and “insufficient,” according to NICE.
In addition, many women report being dismissed, misunderstood, or left without clear pathways to care—often resulting in silent suffering, workplace withdrawal, or career stagnation. [medscape.com]
This is precisely where organisations must take proactive steps, and where specialist clinical support becomes essential.
Dr Morton’s Women’s Health Service: Expert, Accessible Care for Every Woman
At Dr Morton’s Women’s Health Service, we’ve always known that women deserve timely, expert, compassionate menopause care—without stigma, delays, or barriers.
Our service ensures:
✔ Direct access to consultant‑level women’s health doctors
No waiting lists. No gatekeeping. Just expert support when women need it most.
✔ Personalised clinical assessment
Including evaluating whether fezolinetant is appropriate for those unable to take HRT due to medical contraindications or personal preference.
✔ Fast, safe prescribing
Once the medication becomes available on NHS pathways, we can guide women on suitability and ongoing management. Dr Morton’s augments the GP record and makes the whole process seamless!
✔ A holistic, dignified approach
We never minimise symptoms. We listen, we advocate, and we treat women as whole people—not just patients.
When women feel supported, they thrive. And when they thrive, organisations thrive too.
A Call to Employers: Support Women, Strengthen Your Workforce
If you are committed to creating a healthy, resilient, high‑performing workplace, then supporting your menopausal employees isn’t optional—it’s essential.
Here’s what you can do:
- Promote access to clinical expertise
Partner with services like Dr Morton’s where women can quickly speak to a consultant gynaecologist. - Update your menopause policy
Include new treatment options such as non‑hormonal medication, and ensure women know they’re entitled to support. - Encourage open dialogue
Reduce stigma. Normalise conversations. Create safe channels for disclosure. - Invest in wellbeing
Menopause support is not a “perk”—it’s a productivity strategy.
The approval of fezolinetant marks a turning point. It’s time to ensure women who have waited too long for effective relief finally receive the care they deserve.
Dr Morton’s Is Here to Help
We are ready to support women—and the employers who value them—through this new era of menopause care. Whether through personalised consultations, expert prescribing, or ongoing clinical guidance, Dr Morton’s Women’s Health Service stands as the trusted partner for women’s health at work.
Because when women feel heard, healthy and happy, everyone benefits!
